A national team of experts will advance an innovative biopolymer particle-based platform technology to develop vaccine candidates to protect against biowarfare threats.
Griffith University researchers are on the brink of a technological breakthrough in vaccine development with a possible new vaccine modality.
Griffith University researchers have developed a potential vaccine for a pathogen causing severe infection in immunocompromised people.
Scientists develop low-cost platform which could detect early cancer
Griffith University and Queensland-based Luina Bio has announced they have entered into a Memorandum of Understanding (MoU) targeting the development of a vaccine against COVID-19. Luina Bio said it brings contract manufacture capabilities and experience to the collaboration as one of Australia’s most experienced biopharmaceutical contract manufacturing organisations. Griffith University’s Centre for Cell Factories and […]
Griffith researchers develop smart materials platform capable of aiding in the creation of new drugs and the clean-up of polluted environments.